VISION NEWS SOURCE

X
X
X

Filters close
Released: 7-Jun-2023 7:05 AM EDT
IIT Kanpur Pioneers Ground-Breaking Gene Therapy Technology for Hereditary Eye Diseases
Indian Institute of Technology Kanpur

IIT Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt. Ltd. that has the potential to revolutionize the field of gene therapy, especially for many genetic eye diseases, making it the first time that a gene therapy related technology has been developed and transferred from an academic institution to a company in India.

Newswise: Novel surgical technique may be more effective in treating common eyelid disorder
Released: 5-Jun-2023 11:15 AM EDT
Novel surgical technique may be more effective in treating common eyelid disorder
UT Southwestern Medical Center

A novel, minimally invasive surgical technique for correcting blepharoptosis – often called “droopy eyelid” – is more efficient and produces better results than the traditional method that uses sutures, according to a UT Southwestern Medical Center study. The findings, reported in the American Journal of Ophthalmology, may lead to a shift in how oculoplastic surgeons treat this common condition.

Released: 1-Jun-2023 4:55 PM EDT
Eye drops slow nearsightedness progression in kids, study finds
Ohio State University

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

Released: 30-May-2023 4:05 PM EDT
28th Annual Glaucoma Foundation Think Tank Set for June 9/10
The Glaucoma Foundation

Established in 1995, the Glaucoma Foundation's Annual Think Tank has significantly increased the number of people around the world working in the field of glaucoma. All of the speakers at this 2-day will attend in person and the conference will be live-streamed on Zoom.

Released: 30-May-2023 8:05 AM EDT
Patricia A. D'Amore, PhD, MBA, FARVO, named 2023 - 2024 ARVO President
Association for Research in Vision and Ophthalmology (ARVO)

Last month at its 2023 Annual Meeting in New Orleans, La., the Association for Research in Vision and Ophthalmology (ARVO) welcomed Patricia A. D’Amore, PhD, MBA, FARVO, as its new president for April 2023 – May 2024. A member for more than 40 years, D’Amore is a Gold Fellow of ARVO (FARVO) ― a recognition of her individual accomplishments, leadership, and contributions to the Association.

Newswise:Video Embedded glaucoma-research-foundation-celebrates-45-years-of-scientific-innovation
VIDEO
Released: 25-May-2023 5:05 PM EDT
Glaucoma Research Foundation Celebrates 45 Years of Scientific Innovation
Glaucoma Research Foundation

Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the keynote speaker.

Newswise: Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Released: 25-May-2023 2:00 PM EDT
Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
Johns Hopkins Medicine

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.

Newswise: AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Released: 24-May-2023 9:00 AM EDT
AI Used to Advance Drug Delivery System for Glaucoma and Other Chronic Diseases
Johns Hopkins Medicine

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

   
Released: 23-May-2023 11:45 AM EDT
Are we truly “inattentionally blind”? New study revisits “invisible gorilla” experiment for new insights
New York University

We are quite good at spotting unexpected objects while focused on another activity if they are moving fast, reveals a new study by a team of New York University researchers.

Released: 22-May-2023 3:30 PM EDT
Dr. Louis R. Pasquale Winner of the Glaucoma Foundation’s 2023 Robert Ritch Award
The Glaucoma Foundation

The Robert Ritch Award recognizes the contributions of individuals who have played a significant and unique role in promoting the medicine and science of glaucoma.

Newswise: Study: Blood Vessel Damage Could Be an Alzheimer’s Driver
Released: 19-May-2023 8:05 PM EDT
Study: Blood Vessel Damage Could Be an Alzheimer’s Driver
Cedars-Sinai

Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer’s disease, according to research from Cedars-Sinai investigators published in the peer-reviewed journal Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

Newswise: 039_visual_processing_before_moving_hands_fig1.jpg
Released: 18-May-2023 5:45 PM EDT
Visual processing before moving hands: insights into our visual sensory system
Tohoku University

Our hands do more than just hold objects. They also facilitate the processing of visual stimuli. When you move your hands, your brain first perceives and interprets sensory information, then it selects the appropriate motor plan before initiating and executing the desired movement.

Newswise: BGSU develops dimmable protective eyewear for U.S. Department of Defense
16-May-2023 10:10 AM EDT
BGSU develops dimmable protective eyewear for U.S. Department of Defense
Bowling Green State University

BGSU is partnering with public and private organizations to provide the U.S. Department of Defense with eyewear that electronically adjusts its tint from clear to dark in 0.1 seconds, a critical safety feature.

Newswise:Video Embedded nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells
VIDEO
Released: 16-May-2023 9:30 AM EDT
NEI Scientists publish recipe for making blood vessel cells from patient stem cells
NIH, National Eye Institute (NEI)

Researchers at NIH’s National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries.

Released: 15-May-2023 10:10 AM EDT
Mobius Therapeutics™ to Sponsor Educational Events on Compliance with USP <800>
Mobius Therapeutics, LLC

Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, will initiate a series of professional education sessions, focused on how end users of Mitosol® can achieve compliance with USP <800>, the soon to be implemented and enforced standards for control of hazardous drugs in healthcare facilities.

Newswise: New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Times
Released: 10-May-2023 12:00 PM EDT
New Museum of the Eye Exhibit Explores the Eye as a Cultural Symbol, From Ancient to Modern Times
American Academy of Ophthalmology (AAO)

The Truhlsen-Marmor Museum of the Eye®, the world’s only free, public museum dedicated to the science of sight, today announced the opening of Decoding the Eye: Signs and Symbols, a new exhibit exploring how the eye appears as a symbol throughout time.

Released: 9-May-2023 1:25 PM EDT
New research sheds light on how human vision perceives scale
Aston University

The study, published on 8 May in the journal PLOS ONE, explored the computational mechanisms used by the human brain to perceive the size of objects in the world around us.

Newswise: UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases
Released: 8-May-2023 2:05 PM EDT
UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases
University of California, Irvine

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).

Newswise: Elite Paratriathlete Amy Dixon Will Deliver Keynote at Glaucoma Research Foundation's 2023 Patient Summit
Released: 4-May-2023 5:55 PM EDT
Elite Paratriathlete Amy Dixon Will Deliver Keynote at Glaucoma Research Foundation's 2023 Patient Summit
Glaucoma Research Foundation

Glaucoma Research Foundation (GRF), a national non-profit organization dedicated to finding a cure for glaucoma, has selected visually impaired professional triathlete Amy Dixon as keynote speaker for its 2023 Patient Summit, to be held in Long Beach, California, June 23-24.

Released: 2-May-2023 1:50 PM EDT
Got Retinal Disease? Retina Specialists’ Unique Imaging Tools Can Help Preserve Vision
American Society of Retina Specialists

Advances in early detection and treatment of retinal diseases made possible by retina specialists can preserve sight and virtually eliminate vision loss from conditions such as age-related macular degeneration (AMD), diabetic retinopathy and retinal detachment.


Showing results

120 of 2112

close
0.71534